Drug Trial Radar · NCT06643884
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
24
Planned (sponsor's estimate)
Start
Dec 16, 2024
Primary completion
Nov 30, 2026
Study completion Oct 31, 2027
Sponsor
- Lead sponsor
- Aura BiosciencesIndustry
- Sponsor type
- Industry
- First posted
- Oct 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective is to assess the safety and tolerability of bel-sar treatment in subjects with metastases to the choroid from any primary solid tumor.
Conditions
- Eye Cancer
- Primary Cancer
Interventions
AU-011Drug
AU-011 Via Suprachoroidal Administration with laser treatment
SCS MicroinjectorDevice
Suprachoroidal Injection Device
LaserDevice
Laser Administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in choroidal tumor thickness on B-scan ultrasonography (B-scan) 4 weeks after completion of treatment.Time frame: 4 weeks after completion of treatment
- Change from baseline in choroidal tumor largest basal diameter (LBD) on fundus photos 4 weeks after completion of treatment.Time frame: 4 weeks after completion of treatment
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Byers Eye Institute at Stanford University
Palo Alto, California · Recruiting
Bascom Palmer Eye Institute
Miami, Florida · Recruiting
Massachusetts Eye and Ear
Boston, Massachusetts · Recruiting
Kellogg Eye Center
Ann Arbor, Michigan · Recruiting
Associated Retinal Consultants (ARC) PC
Royal Oak, Michigan · Not yet recruiting
Mayo Clinic
Rochester, Minnesota · Not yet recruiting
Cleveland Clinic, Cole Eye Institute
Cleveland, Ohio · Recruiting
OH State Wexner Medical Center, Havener Eye Institute
Columbus, Ohio · Not yet recruiting
Retina Consultants of Oklahoma
Oklahoma City, Oklahoma · Not yet recruiting
Tennessee Retina, PC
Nashville, Tennessee · Recruiting
Retina Consultants of Texas
Bellaire, Texas · Recruiting
Texas Retina Associates
Dallas, Texas · Not yet recruiting
University of Washington
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.